It has been repeatedly shown that circulating ASP levels are altered in response to pathophysiological conditions in humans, including augmentation in obesity, cardiovascular disease, and type II diabetes (even in the absence of obesity), and their reduction with exercise or weight loss [6, 7]. This evidence concerns the gene C3 and cardiovascular disorder.